SB 328437
SIGMA/SML0207 - ≥98% (HPLC)
Synonym: L-Phenylalanine, N-
CAS Number: 247580-43-4
Empirical Formula (Hill Notation): C21H18N2O5
Molecular Weight: 378.38
MDL Number: MFCD16618397
Linear Formula: C21H18N2O5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C21H18N2O5/c1-28-21(25 |
| InChI key | VMFGCGRAIBLAFY-IBGZPJMESA |
| originator | GlaxoSmithKline |
| Quality Level | 100 ![]() |
| SMILES string | COC(=O)[C@H](Cc1ccc(cc1)[ |
| solubility | DMSO: ≥10 mg/mL |
| storage temp. | 2-8°C |
| Application: | SB 328437 may be used to study CCR3-mediated cell signaling in asthma models. |
| Biochem/physiol Actions: | SB 328437 inhibits the recruitment and migration of eosinophils in allergen models of models. It suppresses the Th2-mediated eosinophil infiltration in the airways. |
| Biochem/physiol Actions: | SB-328437 is a CCR3 Antagonist. |
| Biochem/physiol Actions: | SB-328437 is a potent, selective CCR-3 antagonist (IC50 = 1.6 nM). The compound blockes CCR3 agonist-induced calcium mobilization in CCR3 expressing cells with the following IC50 values: eotaxin, 38 nM; eotaxin-2, 35 nM and MCP4, 20 nM. |
| Features and Benefits: | This compound is featured on the Chemokine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xn,N |
| Risk Statements | 22-50 |
| Safety Statements | 60-61 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352202 |

